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In Brief
Modeling complex diseases with
pathology involving interacting tissues is
difficult when using reverse-engineered
regulatory networks due to the presence
of different networks in a biopsy sample
containing multiple cell types. Chen et al.
introduce an approach for deconvolving
regulatory modules that originate
uniquely in one tissue and apply it to
identify IKZF1 and DLX4 as key
transcriptional regulators in Alopecia
Areata.
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Network-based molecular modeling of physiological
behaviors has proven invaluable in the study of com-
plex diseases such as cancer, but these approaches
remain largely untested in contexts involving interact-
ing tissues such as in autoimmunity. Here, using
Alopecia Areata (AA) as a model, we have adapted
regulatory network analysis to specifically isolate
physiological behaviors in the skin that contribute to
the recruitment of immune cells in autoimmune dis-
ease. We use context-specific regulatory networks
to deconvolve and identify skin-specific regulatory
modules with IKZF1 and DLX4 as master regulators
(MRs). TheseMRsare sufficient to induceAA-likemo-
lecular states in vitro in three cultured cell lines, re-
sulting in induced NKG2D-dependent cytotoxicity.
This work demonstrates the feasibility of a network-
based approach for compartmentalizing and target-
ing molecular behaviors contributing to interactions
between tissues in autoimmune disease.
INTRODUCTION
Systems-level analysis using reverse-engineered regulatory net-
works is an emerging computational discipline that has demon-
strated great promise in the study of complex diseases such as
cancer and Alzheimer’s disease (Aubry et al., 2015; Chen et al.,
2014; Shelanski et al., 2015; Zhang et al., 2013). This approach
enables the modeling of complex physiological behaviors as
modules of genes (subsets of differentially expressed genes
that associate with disease) that are controlled by master regu-
lators (MRs). MRs represent the minimal number of transcription
factors (TFs) that are predicted to specifically activate or repress
a target module and, by extension, the associated physiological
behavior (Carro et al., 2010; Lefebvre et al., 2010). They can be
regarded as molecular ‘‘switches’’ that regulate physiological
behaviors. The inference of MRs is made possible through the
reverse engineering of context-specific regulatory networks us-
ing computational algorithms such as ARACNe (Margolin et al.,
2006a).326 Cell Systems 1, 326–337, November 25, 2015 ª2015 Elsevier IncThese MRs are validated biologically and serve as targetable
‘‘hubs’’ governing disease pathology. These approaches have
proven highly effective for the study of cell autonomous behav-
iors in diseases such as cancer. Physiological behaviors such
as mesenchymal transformation in glioblastoma (Carro et al.,
2010) and oncogenesis in B cell lymphoma or breast cancer
(Chen et al., 2014; Mani et al., 2008), as well as onset of Alz-
heimer’s disease (Zhang et al., 2013) have been functionally
linked to a relatively small number of MRs, which in turn become
the ‘‘bottleneck’’ that can be used to infer driver mutations in pa-
tients (Chen et al., 2014) or become the targets of drug screens
for treatment (Shelanski et al., 2015).
However, this type of computational approach is only starting
to be implemented to target pathogenic, non-cell autonomous
interactions between different tissues such as autoimmune dis-
ease. In particular, inferring MRs cannot be done directly using
typical ARACNe-based analysis because of fundamental as-
sumptions made during the generation of a regulatory network:
(1) that the samples used are relatively pure or represent the
one underlying transcriptional network; and (2) the underlying
molecular behavior of a data set exists at a steady state such
that each sample can be treated as a ‘‘snapshot’’ of regulatory
dependency within the overall network (Basso et al., 2005;
Califano et al., 2012; Margolin et al., 2006b). A contaminated
sample, particularly by a tissue that exhibits a different
context-specific regulatory network, can impair the accuracy
of regulatory predictions. Further, when pathogenesis is depen-
dent on the interaction between the two tissues, there will
always be an artifact correlation between contaminant gene
signatures and the molecular modules that recruit them, but
are expressed in the other tissue. This makes it difficult to
clearly define modules exclusive to one tissue or the other
when analyzing gene expression data generated from a mixture
of the two tissues.
Alopecia Areata (AA) provides an ideal model for such a study
since it is characterized by cytotoxic T cells actively infiltrating
the hair follicles and scalp skin that are typically absent in normal
skin (Xing et al., 2014). AA typically presents as loss of distinct,
random patches of hair that can spread to the entire scalp (alo-
pecia totalis) or the entire body (alopecia universalis) (Olsen et al.,
1999). Previous research from our lab and others has directly
implicated immune genes in AA (Martinez-Mir et al., 2007; Petu-
khova et al., 2010), many of which are shared with other autoim-
mune diseases such as type 1 diabetes, celiac disease, and.
rheumatoid arthritis (Betz et al., 2015; Farh et al., 2014; Petu-
khova et al., 2010). Previous studies have identified infiltration
of cytotoxic CD8-positive, NKG2D-positive T cells into the skin
of AA mice (Xing et al., 2014), and the pathology of AA involves
IFN-gamma-dependent signaling pathways, which are
frequently disrupted in association with immune evasion in
cancer (Dunn et al., 2002; Sato et al., 1998).
Little work has been done to determine if there are intrinsic
factors in the ‘‘end organ’’ (the tissue that suffers autoimmune
attack) that contribute to the disease, such as scalp skin in AA,
making this molecular component a prime target for the analysis.
We predict that pathogenic changes in the molecular profile of
the scalp skin will contain genes that mediate interactions with
the infiltrating T cells. As a corollary, identifying theMRswill grant
regulatory control over the modules that are sufficient to induce
immune recruitment. To study this, we leverage context-specific
regulatory networks for the regulatory deconvolution of a mixed-
signature gene expression profile of AA patients. The goal of this
work was to develop a framework capable of separating mixed
AA tissue biopsy gene expression data into skin-specific mod-
ules of AA pathology and infiltrate recruitment.
We identified a molecular profile of AA that includes the
genetic modules of infiltrate recruitment in the scalp skin by
filtering genes that do not accurately map to a skin-specific
network. This scalp skin signature allowed the subsequent iden-
tification of two MRs of scalp skin contribution to infiltration:
IKZF1 and DLX4. These two genes are expressed in primary
scalp biopsies and are sufficient to induce an AA-like molecular
signature and NKG2D-dependent cytotoxicity in independent,
wild-type cellular contexts, allowing for direct genetic induction
of immune-mediated cytotoxicity.
RESULTS
Initial Definition of a Pathogenic Expression Signature in
AA Reveals the Presence of Local Scalp Skin and
Infiltrating Immune Signals
First, we created a molecular signature comparing AA patients
to controls to generate a molecular representation of AA. We
analyzed a training set of microarray studies of patient biopsies
from an initial cohort of 34 unique biopsy samples: 21 AA
patients of varying clinical presentations and 13 unaffected con-
trols. We additionally had patient-matched, nonlesional scalp
biopsies for 12 of the 21 AA patients. These 34 patients were
gathered as the first of two cohorts totaling 96 patients, the
remainder of which was saved for validation studies.
We created an overall gene expression signature by com-
paring patients of two distinct clinical presentations, patchy AA
(AAP) and totalis and universalis (AT/AU) all against unaffected
controls. To account for artifacts in the signature associated
with secondary effects of infiltration such as hair loss, we then
performed hierarchical clustering using this gene signature on
a set of patient-matched lesional (symptomatic skin with hair
loss) and nonlesional (asymptomatic hair-bearing skin) samples.
This analysis identified gene clusters that were differentially
expressed between these samples and those that were sys-
temically equivalent across lesional and nonlesional samples.
We subsequently removed from the first expression set any
genes that fell in clusters correlating with lesional versus nonle-Celsional states. This primarily removed a significant number (but
not all) of the keratin and keratin-associated proteins from the
signature.
The resulting gene expression signature, the Alopecia Areata
Gene Signature (AAGS), consisted of a total of 136 unique genes
(Table S1) and provided sufficient information to cluster the
entire training cohort into two appropriate superclusters corre-
sponding to the control and disease states (Figure 1A). Clus-
tering these genes by co-expression also revealed two distinct
modules of genes, with greater diversity of co-expression in
the genes upregulated in the disease state (Figure 1B). As a qual-
itative measure of the genes differentially expressed between
affected and unaffected patients, we analyzed them for
functional annotation enrichments. The analysis revealed the
presence of HLA genes, immune response elements, and inflam-
matory and cell death pathway gene expression in the affected
patient samples (Figure 1C). The two most significant super-
clusters of the AAGS were transmembrane signaling peptides
(p = 2.8 3 1011) and secreted cell-cell signaling peptides (p =
2.1 3 1010). As expected, this list also contains several anti-
gen-presenting elements and immune response elements that
are associated with AA and autoimmune disease (Figure S1;
Table S2). These results indicate that there are significant alter-
ations of multiple biological processes in AA-presenting cells.
We postulate that some subset of these genes originate from
the scalp skin and are required to induce infiltration recruitment.
There is also significant evidence for immune-related genes
originating from infiltrating immune cells that must be filtered
beforehand; or else they could confound the identification of
skin-specific molecular programs. Gene markers associated
with immune cells or immune response were detected as part
of the AAGS including CD8a, CXCL9/10, and CCL5/18/20/26 (a
full list can be found in the Supplemental Information). In primary
patient biopsy samples, defining skin-specific molecular behav-
iors contributing to AA is a difficult task due to the presence of
infiltrating T cells and secondary response pathways in AA skin
samples.
Leveraging Regulatory Networks to Deconvolve Skin
and Immune Signatures in the AAGS into Regulatory
Modules
With clear definitions of the disease signature, we sought to
deconvolve the skin molecular program in the AAGS from the
molecular program originating in infiltrating immune cells in a
systemic, unbiased manner. Rather than using GO pathway
enrichment or other annotation-basedmethods that rely on a pri-
ori knowledge and potentially ambiguous annotations, we
instead utilize our inferred regulatory networks under the hypoth-
esis that we can filter nonskin (immune infiltrate) gene expression
by identifying the genes that cannot be mapped to a skin-
specific regulatory network.
A transcriptional regulatory networkof the scalp skinwasgener-
ated using the ARACNe algorithm and associated software suites
(see Experimental Procedures). Specifically, to generate the
network, we included a cohort of 106 primary scalp skin samples
consisting of normal (unaffected) whole skin biopsies and several
samples of primary cultured dermal fibroblasts and dermal papilla
cells, which contain few or no T cell infiltrates. This network repre-
sents the regulatory network in uninfiltrated skin-derived tissuesl Systems 1, 326–337, November 25, 2015 ª2015 Elsevier Inc. 327
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Figure 1. Gene Expression Analysis Iden-
tifies Mixed-Tissue Gene Signatures
(A) Unsupervised hierarchical clustering of a cohort
of AAP, AT/AU, and unaffected controls (Normal)
using the AAGS (blue, underexpression and red,
overexpression).
(B) Gene co-similarity matrix showing gene clus-
ters. The stronger orange indicates lower dissimi-
larity in gene expression. The clusters over- and
under-expressed in AA are indicated.
(C) Graphical representation of genes in the
signature and the statistically enriched functional
categories associated with them. The blue in-
dicates signaling pathways; the yellow indicates
immune/inflammation pathways; the orange in-
dicates HLA; and the red indicates cell death
pathways. The pathways at p < 0.05 FDR corrected
were kept for this analysis.and serves as the cornerstone of the deconvolution, which occurs
in two primary steps as detailed in Figure 2.
For deconvolution of regulatorymodules, the genes in theAAGS
are directly mapped to the regulatory network (Figure 2A; see
Experimental Procedures fordetails). Agene in theAAGS isonly re-
tained if there is a direct regulatory interaction between it and a TF
using the regulatory logic of a skin ARACNe network (red, solid
edges).Anygenes thatcomeuniquely from infiltrating immunecells
will nothavesignificant representation in theARACNenetwork,and
aresubsequently removed fromtheAAGS(black,dottededges) for
skin, and added to an Immune Gene Signature (IGS).
The IGS was used as a ‘‘negative control’’ signature, adapted
from previous work in characterizing cancer immune infiltrates
(Bindeaet al., 2013). The signaturesweredefinedasa set of genes
that are specifically expressed in each immune cell type, including
T cells, B cells, mast cells, and macrophages. This step iteratively
re-defines the AAGS and IGS by separating those genes whose
regulation can be accounted for by an uninfiltrated regulatory
network (AAGS) from those that cannot (IGS).Byextension,weex-
pected the filtered AAGS to be enriched enough in skin gene
expression to generate accurate skin-specific regulons.
As indicated in Figure 2B, 13 infiltrate-specific genes were
removed from the AAGS (9.5% of the total signature) when
passed through the skin-specific regulatory network. These
genes are also listed in Table S1. This resulted in two mutually328 Cell Systems 1, 326–337, November 25, 2015 ª2015 Elsevier Inc.exclusive gene modules (no overlapping
genes, p = 1.77 3 104), the AAGS and
the IGS. A subsequent pathway enrich-
ment analysis further confirmed loss of
statistical enrichment of the ‘‘T cell activa-
tion’’ and ‘‘Immune response’’ categories
(see Table S2), while retaining the other
clusters including known skin immune
response elements (such as the HLA
genes). This left a total of 123 genes in
the AAGS that we interpret to represent
all end-organ programs associated with
AA pathology, including end-organ-initi-
ated immune recruitment and immune
response (Table S1, starred entries).Note that we have made the distinction between annotations
associated with immune cells (e.g.,CD8a) and annotations asso-
ciated with immune response genes (e.g., HLA). The former are
removed by the regulatory network as unrepresented in a skin
regulatory network. The latter are signature genes that we aim
to keep, as they represent the response elements in the skin
and are relevant for the pathology of the disease.
Clustering the filtered AAGS revealed two distinct molecular
modules that define the transition from unaffected patients
(Figure 2B, second) to an AA disease state (Figure 2B, third).
Each node represents a gene in the signature, and its size repre-
sents the relative expression in each state (larger means higher
expression). We labeled these gene groups: (1) genes whose
expression is increased when transitioning into the disease
state, and (2) genes whose expression is lost in the transition.
This filtered AAGS reflects end-organ-specific gene modules
and served as the input to our MR analysis.
IKZF1 and DLX4 Are MRs of the Skin AAGS and, by
Extension, Infiltrate Recruitment
The next step is themost important in identifying end-organ-spe-
cific MRs. We performed MR analyses on both the deconvolved
AAGS and the IGS independently and in parallel using the scalp
skin regulatory network (Figure 2C, first, red outline). Using only
regulatory interactions represented in skin, we identified the
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Figure 2. Identification of IKZF1 and DLX4 as MR
An overall flow of the pipeline used to deconvolve regulators of genes expressed in the end organ (skin) from those expressed in infiltrating tissue (immune cells).
(A) Genes (aqua nodes labeled A–F) measured from a complex primary tissue sample are assigned to either end-organ (red, AAGS) or infiltrate (blue) based on
whether or not they can be mapped to regulators in the skin network (R). Only the genes mapped to the red node are considered for MR analysis. The genes
mapped to the blue node are pruned away.
(B) The resulting pruning of the AAGS provides an end-organ-enriched gene expression signature (aqua nodes) that is mutually exclusive with an IGS, p = 1.773
104, that is overexpressed (cluster 1, node sizes proportional to fold change) and suppressed (cluster 2) in AA.
(legend continued on next page)
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transcriptional regulators that had the highest specificity for the
deconvolved AAGS (red arrows) and repeated the analysis for
the IGS (black arrows). This step compares the AAGS against
the IGS in terms of regulatory logic in the scalp skin, as opposed
to direct coverage of gene expression. This analysis assays
which TFs are the best candidates for the deconvolved AAGS
(and not for the IGS) using a molecular regulatory network spe-
cific to the skin. We identify skin-specific candidate MRs by
keeping only the candidates that were both significant in AAGS
coverage and insignificant for IGS coverage.
Of the significant candidate MRs specifically for the AAGS,
we employed a greedy sort to identify the fewest number of reg-
ulators needed tomaximize the coverage of the AAGS.We found
that two MRs were sufficient to cover >60% of the AAGS: IKZF1
and DLX4. Any additional candidates boosted the coverage by a
statistically insignificant margin (<5%). We conclude that the
maximum AAGS fidelity (most faithful recreation of the expres-
sion signature) andefficiency (fewest necessary regulators) could
be achieved through these two genes (IKZF1 p= 4.173 104 and
DLX4 p = 4.8 3 1010 FDR-corrected).
An equivalentMRanalysis conductedon the IGSmodules failed
to generate any statistically significant or meaningful MRs when
using the scalp-skin regulatory network.Specifically, thebest can-
didates for theAAGS, IKZF1andDLX4, fall to statistical irrelevance
(falling from first and second to 159th and 210th, respectively,
FDR = 1) (Figure 2C, IGS.FDR). Conducting the MR analysis on
the AAGS without deconvolution fails to generate MR candidates
at the threshold that is typically expected (both in p value and
signature coverage) due to the presence of contaminating genes
in the signature which cannot accurately be mapped to a MR,
but nonetheless count against enrichment in the analysis.
These two candidates represent the minimum number of reg-
ulators required to recreate the AAGS using regulatory interac-
tions derived from a specific tissue context (scalp skin), distinct
from any immune-specific regulatory modules that were decon-
volved away using this method. IKZF1 and DLX4 therefore
represent a genetic regulatory module in the scalp skin that con-
tributes to AA pathogenesis (Figure 2C, last) and may be suffi-
cient to induce infiltration recruitment in an AA-like manner.
The identification of IKZF1 was unexpected, since it is a well-
established T cell differentiation factor, though it is not without
precedent that IKZF1may have a role in cells outside the immune
system (Javierre et al., 2011). However, it is important to note that
this analysis doesnot imply that aMRsuchas IKZF1hasno role in
T cells contributing to AA pathogenesis, but rather, that there is
significant evidence that IKZF1 additionally functions in the scalp
skin to mediate the interactions between the tissues.Expression of IKZF1 and DLX4 Induces an AAGS-like
Signature in Normal Hair Follicle Dermal Papillae and
Human Keratinocytes
To validate our MR predictions with functional studies, we exog-
enously overexpressed IKZF1 and DLX4 in skin-derived cell(C) To deconvolve the scalp skin regulators, we performedMR analysis on the AAG
the skin (R2) will only appear when using the AAGS and not in the IGS. The infiltrate
have significant FDR values when using the AAGS and are insignificant (FDR = 1
(aqua squares) and MRs (yellow squares) in the skin (right).
330 Cell Systems 1, 326–337, November 25, 2015 ª2015 Elsevier Inclines and cultured cells to test for sufficiency in influencing
expression of the AAGS. We cloned DLX4 and two isoforms of
IKZF1 for exogenous expression in cultured cells. The active
IKZF1 isoform served as the experimental arm of the study, while
the isoform that lacks a DNA binding domain was included as a
negative control (IKZF1d). We expressed these genes in cultured
primary human hair follicle dermal papillae (huDP) and human
keratinocytes (HK). This experimental system allowed us to
directly test two distinct, but related, hypotheses: (1) IKZF1
and DLX4 can induce AA-like recruitment of immune cells, and
(2) they do so through expression in the skin (not the immune
infiltrates).
We identified a set of genes that were significantly differentially
expressed in the same direction in IKZF1 andDLX4 transfections
across both cell types. Unsupervised hierarchical clustering of all
samples based on these transcripts reveals clean co-segrega-
tion of IKZF1 and DLX4 transfections from IKZF1d and RFP
(red fluorescent protein) controls (Figure 3A). Furthermore, we
observed that the subclustering within these supergroups was
not biased based on cell type used (HK did not cluster with
HK, and DP did not cluster with DP), supporting that we have
identified context-independent effects of MR overexpression.
Interestingly, we observed that DLX4 transfections resulted in
increased levels of IKZF1 transcript and protein, whereas the
IKZF1 transfections did not influence DLX4 expression (Figures
3B and 3C).
We subsequently interrogated the expression data for enrich-
ment of the AAGS genes using gene set enrichment analysis
(GSEA). We performed two differential gene expression studies
comparing the IKZF1 transfections versus RFP controls and
DLX4 transfections versus RFP controls. The results show that
the ectopic expression of the MRs is followed by significant
enrichment in the induction of the AAGS (IKZF1 p = 0.012 and
DLX4 p = 2.08 3 104; Figures 3D and 3E).IKZF1 and DLX4 Expression Are Sufficient to Induce
NKG2D-Mediated Cytotoxicity in Normal Cultured Skin
IKZF1 and DLX4 overexpression suggest that these two genes
are MRs capable of mediating the AAGS when applied to HK
and huDP. However, the functional relevance of these MRs to
autoimmunity and immune infiltration is whether or not their
expression is sufficient to induce a targeted autoimmune
response. In order to investigate this ex vivo, we performed
experiments measuring the level of cytotoxic cell death in HK
and huDP cells when exposed to peripheral blood mononuclear
cells (PBMCs).
We again transfected both HK and huDP cells with one of four
expression constructs: IKZF1, DLX4, RFP (negative control), or
IKZF1d (negative control). At 24 hr post-transfection, these cells
were incubated with fresh, purified PBMCs. We additionally
cultured human dermal fibroblasts and autologous healthy donor
PBMCs. The PBMCs were obtained from a healthy control sub-
ject with no history of AA or any other autoimmune disease.S and the IGS, yielding candidate regulators of each signature. The trueMRs in
regulators (R1) will not be detected using the AAGS. The IKZF1 andDLX4 only
) when using the IGS, left. This analysis establishes IKZF1 and DLX4 as AAGS
.
Figure 3. Exongeous Expression of IKZF1
and DLX4 Induces a Context-Independent
AA-like Gene Expression Signature
(A) 2D hierarchical clustering of gene expression
measured in huDP and HK transfected with
plasmid vectors expressing IKZF1, DLX4, or con-
trols expressing RFP and IKZFd, an isoform lacking
DNA binding domains. The treatment type and cell
type for each experiment are indicated at the top
of the heatmap. The blue indicates decreased
expression and the red indicates overexpression.
(B) Analysis of IKZF1 and DLX4 mRNA expression
in transfected cells in quadruplicate, represented
as average ± SEM, normalized to B-actin.
(C) Western blot confirming IKZF1 and DLX4 pro-
teins. The GSEA plots measuring the specificity of
AA-like response assayed by differential expres-
sion of the AAGS following (D) IKZF1 or (E) DLX4
overexpression. The genes are ranked left to right
from most- to least-differentially expressed on the
x axis and barcodes represent the positions of
IKZF1 and for DLX4 signature genes. The Enrich-
ment Score (ES) is shown in the plot, and the
normalized Enrichment Score (nES) is displayed at
the top. The nES is derived from the ES at the
‘‘leading edge’’ of the plot, that is, the first maximal
ES peak obtained. The p value is computed for the
nES compared against a randomized null
distribution.In all comparisons, we observed a statistically significant
increase in PBMC-dependent cytotoxicity for the IKZF1 and
DLX4 transfections compared to RFP and IKZF1d controls
(Figure 4, center columns, total bar height). The patient-matched
PBMCs andRFP-control transfected fibroblasts exhibited no ev-
idence of cytotoxic interactions, as expected in healthy target
cells (Figure 4A, center). However, the introduction of IKZF1
and DLX4 were both sufficient to induce an interaction between
these previously non-interacting cells, resulting in significant
increase of total cytotoxicity. In a similar fashion, both huDP (Fig-
ure 4B, center) and HK cells (Figure 4C, center) showed a signif-
icant increase above background levels in cytotoxic sensitivity to
the PBMCs.
Since we previously showed that the likely pathogenic
immune cells in AA are CD8+ NKG2D+ activated T cells, weCell Systems 1, 326–337, Nalso performed all treatments with the
addition of an NKG2D-blocking antibody
(see Experimental Procedures) to pre-
vent NKG2D-dependent interactions. In
all cases, we observed that blocking
NKG2D suppressed the cytotoxicity in
both IKZF1 and DLX4 treatments to
levels comparable to controls (Figure 4,
center, gray bars). From the difference
between the inhibitor-treated and un-
treated cells, we can infer the cytotox-
icity that is NKG2D-dependent (Figure 4,
center, white bars), which can be
normalized to that observed in controls
for a relative fold change analysis. From
the NKG2D blockade, we observed astatistically significant increase specifically in IKZF1 and DLX4
transfections across all trials (Figure 4, right). There was a large
(>50-fold) increase in patient-matched cytotoxicity compared
to the control transfection, which again showed no significant
cytotoxicity. There was approximately a 2- to 8-fold increase
in NKG2D-dependent cytotoxicity compared to both controls,
despite a statistically significant, but small (<10%), increase
in NKG2D-independent cytotoxicity. We conclude from these
experiments that IKZF1 and DLX4 are capable of inducing
NKG2D-dependent interactions with normal PBMCs that result
in toxicity for the transfected cells irrespective of the exact
tissue type.
Importantly, these experiments establish the cell autonomous
function for IKZF1 andDLX4 in the scalp skin as opposed to infil-
trating cells, since the exogenous modification was done strictlyovember 25, 2015 ª2015 Elsevier Inc. 331
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Figure 4. Exogenous Expression of IKZF1 andDLX4 Induces IncreasedNKG2D-Dependent PBMC-Associated Cytotoxicity in Three Cultured
Cell Types
The schematic on the left of each row describes the tissues introduced to PBMCs for cytotoxicity assays (in triplicate). The colors indicate host sources (matching
colors indicate host-matched tissues). The middle bar graphs present the cytotoxicity values obtained after either 6 hr of incubation (total bar height) or the
cytotoxicity observed after 6 hr with the addition of human anti-NKG2D monoclonal antibody (gray bar). The NKG2D-dependent cytotoxicity is the difference
between the two (white bar). The right bar graphs report the changes in NKG2D-dependent cytotoxicity normalized to the RFP controls. IKZF1.2B indicates cells
transfected with the IKZF1d vector, and IKZF1.3B indicates the full-length transcript. The y axis reports cytotoxicity measured as a fraction of maximum cyto-
toxicity (total cell count). All error bars report ± SEM. ** indicate statistically significant difference from RFP control at FDR <0.05.
(A) Dataseries corresponding to WB215J PBMCs and WB215J fibroblasts.
(B) WB215J PBMCs against cultured huDP.
(C) WB215J PBMCs against cultured HK.on normal cultured cells and exposed to healthy PBMCs from a
source with no history of autoimmune disease.
MR Expression Permits Reconstruction of a Directional
Skin-Specific MR Module of Infiltration Recruitment
After establishing that IKZF1andDLX4are sufficient to induce the
AAGS, we sought to use this data to fully reconstruct the AA MR
module. ARACNe is capable of detecting direct transcriptional
dependencies between a TF and nonregulatory genes that are
potential targets (T) because we can infer that the regulation is332 Cell Systems 1, 326–337, November 25, 2015 ª2015 Elsevier IncTF/ T. ARACNe cannot infer directional interactions between
TF-TF pairs and subsequently cannot infer secondary T of MRs
due to the regulatory equivalence of TFs (Figure 5A, first). Howev-
er, sincewe have directly perturbedHKs and huDPswith specific
MRs (Figure 5A, asterisks), we can use the gene expression data
to infer directionality. If TFB is a T of our MR (TFA), then overex-
pression of TFA will result in the differential expression of TFB
and we can infer that TFA / TFB. Subsequently, any marker
genes in the signature associated with TFB can be linked to MR
as secondary T TFA/ TFB/ T (Figure 5A, top). If TFB functions.
A B
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Figure 5. The Fully Reconstructed Master
Regulator Module Predicts Both Immune
Infiltration and Severity
(A) Using the exogenous expression data, it is
possible to infer both direct transcriptional MR T
(MR/ T), as well as T regulated by TFs that are T of
the MR (MR/ TF/ T). Any TF (TFB) that is paired
with MRs IKZF1 or DLX4 (TFA) and that exhibits
changes in expression upon overexpression of the
TFA is regulated by the TFA. Subsequently, any
genes (T) in the AAGS that are linked to TFB are
secondary T of TFA (TFB responds). Any TFB that
does not respond to transfection of TFA is not
regulated by the TFA, so either TFB regulates TFA
(TFB stable, left) or both are co-regulated by a third,
TFC (TFB stable, right).
(B) Using this approach, 78% of AAGS can be
mapped to IKZF1 or DLX4 within one indirect TFB.
The blue nodes represent AAGS genes that respond
to IKZF1 or DLX4 expression, the size of nodes
scaled to the fold change experimentally observed
(only nodes having at least 25% change are shown).
(C) Using these T, we generate single numeric
scores of IKZF1 and DLX4 transcriptional activity
and used them to create classifiers for AA severity.
The AA samples are then imposed over the search
space to assess accuracy (top chart). The table
provides quantitation and statistics for separation of
presentations across territories in the search space
(unaffected: NC; patchy AA: AAP; and totalis/uni-
versalis: AT/AU). The centroid representations can
be used to show how populations transition into
disease states by moving across the trained
boundaries (bottom chart; nonlesional: AAP-N and
lesional: AAP-L).upstream of or in parallel with MR then the expression of TFB and
T will not be affected by overexpression of TFA (Figure 5A,
bottom).
Using this logic, we reconstructed the regulatory module to
measure the full extent of the coverage obtained by overex-
pressing IKZF1 and DLX4 in these cellular contexts. We mapped
any downstream T of TFs that both (1) respond to IKZF1/DLX4
expression in the experiments, and (2) are predicted to have
mutual information with the expressed MR by ARACNe to
the regulatory module. We found that 78% of the responding
AAGS are within 2 of downstream separation from the MRs
IKZF1 and DLX4 based on these criteria (Figure 5B; full module
listed in Table S4).
IKZF1 and DLX4 Can Be Used to Predict Both Immune
Infiltration and Disease Severity in an Independent
Cohort
As validation of this module, we returned to our original AA array
cohort and performed amachine-learning analysis.We attemptedCell Systems 1, 326–337,to classify a validation AA set into control
and affected samples using only the inferred
IKZF1 and DLX4 activity. Using the earlier
training set from Figure 1, we arrayed the
samples into a search space of two dimen-
sions: the consensus activity of IKZF1(x axis), and the consensus activity of DLX4 (y axis) (see Experi-
mental Procedures). From the training set, we generated a topo-
graphical map of the consensus activity space to define ranges
of IZKF1 and DLX4 activity associated with control samples,
patchyAA, andAT/AU samples (Figure 5C, black lines). The region
in Figure 5C closest to the origin of the plot represents the lowest
combined IKZF1 and DLX4 activity; its upper bound (the lower
black line) is the support vector machine (SVM) margin that maxi-
mizes the difference between control and all AA patients. The next
upper bound (the upper black line) represents theSVMmargin that
maximizes the separation of AT/AU patients from AAP.
Using these measures of MR activity, we turned to the valida-
tion set and tested for the predictive power of these parameters
in separating patients and controls. We observed a strong ability
to separate samples into disease and control states, in addition
to clinical severity (Figure 5C, top, p < 13 105). A centroid map
of each patient subgroup more clearly reveals how the transition
of patient groups from Control (NC) to AAP and AT/AU is re-
flected by relative IKZF1 and DLX4 activity (Figure 5C, bottom).November 25, 2015 ª2015 Elsevier Inc. 333
p-value tail
AA vs AD 0.003 left
AA vs Ps 3.93x10-13 left
AD vs Ps 0.0173 right
A
ADPs
71
2221
178
1
13
216
AA
Ps
AD
psoriasis Ps p-value IGS p-value
POL2R2 2.02x10-4 1
SOX15 2.07x10-5 1
HTLF 8.36x10-5 1
SMAD2* 5.06x10-5 1
TGFBR1* 4.75x10-5 1
atopic.derm AD p-value IGS p-value
HLTF 1.78x10-7 0.944
SMAD2 1.96x10-5 0.990
ETS1 4.13x10-5 0.817
RB1 4.16x10-5 0.707
CIR1 7.42x10-5 0.320
*studied in published work in psoriasis
common MR in psoriasis and AD
AA
AD
Ps
B
Figure 6. Deconvolved Regulatory Modules
Can Be Generated for AA, Ps, and AD Using
the Same Naive Framework
(A) Disease-associated gene expression signatures
for Ps and AD can be clearly defined by differential
expression. The comparison of these signatures to
the AA gene signature reveals that the AA signature
is statistically distinct from both Ps and AD signa-
tures (Fisher’s exact test), whereas there is statis-
tical evidence for some sharing between the Ps and
AD signatures.
(B) Translating these signatures into regulatory
modules reveals entirely different MRs governing
AD and Ps compared to AA. The yellow nodes = AA
gene signature; the blue nodes = AD gene signa-
ture; the aqua nodes = Ps gene signature; the or-
ange nodes = AA MR; the dark blue nodes = AD
MR; and the cyan nodes = PsMR. The list of top five
AD and Ps MRs are provided, ranked by coverage
of the corresponding signature. Also provided are
the p values of eachMRwithout deconvolution (IGS
p value) (* indicates published regulators and y in-
dicates an MR common to AD and Ps).For comparison, we also included a centroid for the AAP
nonlesional sample biopsies, which were not included in the
training set.
Deconvolution Applied to Independent Inflammatory
Skin Diseases Identifies Known Genes
For comparison, and to provide proof-of-concept for the gener-
alizability of our approach, we downloaded publicly available
gene expression data sets for atopic dermatitis (AD) (Sua´rez-
Farin˜as et al., 2011) and psoriasis (Ps) (Yao et al., 2008). We
generated gene expression signatures for each disease by
comparing lesional biopsies to unaffected biopsies, similar to
our AA analysis (Figures 6A and S2; Table S3). A direct compar-
ison of the genes within the AA, AD, and Ps signatures revealed
statistically significant evidence that the AAGS is distinct from
both AD and Ps (p = 0.003 and 3.93 3 1013, respectively).
By contrast, comparison of the AD and Ps signatures to each
other revealed statistically significant evidence for shared mo-
lecular signatures and, by extension, possible shared molecular
pathology (p = 0.0173).
These two signatures were applied to our pipeline. Figure 6B
reports the top five MRs identified after the analysis, ranked by
their total coverage of the appropriate disease signatures (Ps
or AD). Also provided are the ranks of the MRs using the corre-
sponding deconvolved IGS. The results indicate that the key reg-
ulatory hubs associated with AA (specifically IKZF1 and DLX4)334 Cell Systems 1, 326–337, November 25, 2015 ª2015 Elsevier Inc.are unique to AA. Each disease was as-
signed its own unique list of MRs, but
there additionally was overlap of two
candidate MRs in AD and Ps: SMAD2
and HLTF. SMAD2 and TGFBR1 are TFs
with published evidence of involvement
in Ps, and our pipeline was able to identify
them with no a priori evidence, using a
basic definition of a Ps gene expression
signature (Doi et al., 2003; Gambichleret al., 2013). These results demonstrate the effectiveness of
modeling complex genetic behaviors as regulatory modules to
differentiate mechanisms of pathology.
DISCUSSION
Systemic generation and analysis of gene regulatory networks
and gene expression data capitalizing on genome-wide profiling
has proven to be instrumental in the study of complex diseases.
Integrative projects to interrogate functional interactions have
recently been leveraged in genome-wide expression signature
deconvolution (Bindea et al., 2013; Newman et al., 2015) and
cross-tissue interactions (MacNeil et al., 2015) in diabetes and
atherosclerosis (Hecker et al., 2009; Keller et al., 2008). These
studies have been invaluable in identifying infiltrating gene signa-
tures, which provide insight into the types of pathogenic immune
infiltrates associated with disease. They have also helped iden-
tify driver genes from eQTLs and other genomic association
tests, similar to the systematic algorithms being developed in
cancer and Alzheimer’s disease research (Chen et al., 2014;
Zhang et al., 2013) by providing significant genome-level
coverage of regulatory activity and tissue-level gene panels of in-
teracting tissues.
However, particularly in contexts such as AA, little has been
done to characterize the modular regulation of discrete patho-
genic molecular behaviors within a gene expression profile and
how they translate to physiological interactions between tis-
sues of the disease. Modeling physiological traits as genetic
programs controlled by MRs provides a uniquely powerful
perspective in the study of complex disease. The approach
canalizes large gene expression signatures into a relatively
few number of selected MRs that subsequently become the T
of manipulation via gene therapies or drugs and small
molecules.
Here, we extend the application of regulatory networks to
interrogate the complex molecular state of a mixed sample of
end organ (scalp skin) and infiltrating (immune infiltrates) tissue
in AA by comparing regulatory networks of different skin con-
texts (infiltrated and normal). We establish that in addition to their
typical use for identifying the key regulatory hubs governing mo-
lecular phenotype switches, these networks can be used to
isolate and compartmentalize molecular behaviors that originate
from different tissues based on whether or not they are accu-
rately represented in an independent context-specific network.
This allows for more precise identification of tissue-specific
molecular programs from a mixed sample that contribute to an
integrated, interactive physiological behavior such as immune
infiltration. Using this pipeline, we were able to reconstruct the
MRs mediating infiltration from the skin not only in the context
of AA, but our analysis of Ps and AD provides additional candi-
dates for the genetic regulation of inflammatory skin diseases
in general, and demonstrates the general applicability of the
approach.
Aside from the direct implications in AA pathology, this work
provides the proof-of-principle for two key, generalizable
notions: (1) a complex interaction between two tissues can be
modeled as quantifiable, molecular gene expression modules;
and (2) these modules and their regulators can be extracted
from expression data, compartmentalized to a tissue, and co-
opted to induce the associated interaction in normal cell types.
This was evidenced by our ability to recapitulate the AAGS
upon ectopic expression of MRs IKZF1 and DLX4 and to subse-
quently induce enhanced cytotoxicity in non-AA cell lines using
normal (non-AA) PBMCs solely via the manipulation of IKZF1
and DLX4 expression within the end organ itself (no genetic
manipulation of the PBMCs).
Specifically, our analysis identified MRs that are sufficient to
induce interactions with immune cells when expressed solely
in scalp skin. Even in a patient-matched context with samples
from a healthy, AA-unaffected patient, IKZF1 and DLX4 expres-
sion were sufficient to induce aberrant NKG2D-depedent inter-
actions between dermal fibroblasts and PBMCs resulting in
cytotoxicity. These interactions were not present in control
transfections and they were repeated in two other (nonpatient-
matched) cell types, indicating that the expression of IKZF1 or
DLX4 is sufficient to induce interactions with normal immune
cells irrespective of the specific tissue or host matching. The
identification of IKZF1 and DLX4 would have been impossible
without our network-based deconvolution, since the significant
presence of infiltrating signature in the original AAGS would
have prevented any accurate identification of candidate MRs.
Instead, network-based deconvolution identified MRs that are
capable of inducing specific molecular interactions in any of
several molecular contexts that are completely independent of
AA itself.CelThe identification of IKZF1 was unexpected, since IKZF1 is
widely studied in the context of T cell differentiation (Kleinmann
et al., 2008). However, its identification came solely from using a
deconvolved AA signature, and not the IGS, using regulatory logic
derived from skin. Had we relied on public databases, previous
literature, or GO annotations to filter our gene expression data,
we would have disregarded and removed IKZF1 entirely due to
extensive annotation as a T cell differentiation factor. Instead, by
turning to regulatory networks, we were able to identify the possi-
bility that local expression of IKZF1 could have a pathogenic rele-
vance independent of its established role directly in immune cells.
While IKZF1 is well characterized in the context of immune
cells, a role for IKZF1 outside of immune cells is not without pre-
cedent in the literature. The losses of IKZF1 and DLX4 loci are
also associated with oncogenesis in colorectal, lung, and breast
cancers, and low-grade squamous intraepithelial lesions (Jav-
ierre et al., 2011; Sakane et al., 2015; Tomida et al., 2007). These
studies obtain their genomic information directly from tumor
masses, indicating that somatic losses of these two loci can
contribute to cancer pathophysiology as end organ genomic al-
terations. Our studies into IKZF1 and DLX4 as MRs inducing im-
mune infiltration support these results and raise the possibility
that the loss of these loci may contribute to immune evasion in
cancer. Further, these observations, and the identification of
IKZF1 and DLX4 as MRs of immune infiltration recruitment, pro-
vide support that there is a function for IKZF1 outside of its role
as a T cell-specific differentiation factor and raises support for
the hypothesis that autoimmunity in AA and tumor immune-
evasion exist at opposite extremes of normal immune interac-
tions. The loss of the MRs of immune infiltration is associated
with cancer, and their overexpression is associated with the
onset of autoimmune disease in AA.
We have shown that systems biology and network analysis
can be used to model the molecular mechanisms mediating
interactions between two distinct tissues, identify the key regu-
lators, and use them to re-create the interactive trait in other con-
texts. While the output for the validation of these MRs was
ultimately induction of cell death, the function of these MRs in
the context of autoimmune disease is to induce a molecular pro-
file that ultimately signals to and recruits immune infiltrates. Up to
this point, applications of systems biology have mainly been to
identify ‘‘breakpoints’’ in cell-autonomous molecular behaviors
of cancers. The controlled induction of cross-tissue interactions,
particularly those involving the immune system, invites poten-
tially significant avenues for modeling complex genetic traits
with regulatory networks that has previously not been feasible.
We provide a proof-of-concept framework that can be used to
actively compartmentalize molecular behaviors for study even
in complex diseases involving interactions between different
tissues.
EXPERIMENTAL PROCEDURES
This section contains a description of the less common or unique methods im-
plemented in this study. The remaining methods are detailed in Supplemental
Information.
ARACNe
To generate a context-specific transcriptional interaction network for scalp
skin, we employed the ARACNe algorithm (Margolin et al., 2006a) on a setl Systems 1, 326–337, November 25, 2015 ª2015 Elsevier Inc. 335
on of 128 microarray experiments independent of the analytic cohorts in this
study. These experiments represent platform-matched (Affymetrix U133
2plus) data acquired on whole skin samples from a mixture of normal whole
skin biopsies, AA patient biopsies, microdissected dermal papillae, and sepa-
rated dermis and epidermis samples. These samples collectively provide the
heterogeneity required for accurate detection of transcriptional dependencies
in the scalp skin. The experiments were pooled and post-processed as
described above and a standard ARACNe analysis was performed. The ARA-
CNe software suite is available from the Califano lab website, http://wiki.c2b2.
columbia.edu/califanolab/index.php/Software.
MR Analysis
MRs for a specific gene expression signature were defined as TFs whose
direct ARACNe-predicted T (regulon) are statistically enriched in the gene
expression signature. Each TF’s regulon was tested for enrichment of the
AAGS using Fisher’s exact test, FDR = 0.05. This analysis allows for the
ranking and determination of the minimum number of TFs required to specif-
ically cover a gene expression module associated with a physiological trait.
http://wiki.c2b2.columbia.edu/califanolab/index.php/Software/MARINA
MR Activity Classifiers
The ARACNe-predicted T of IKZF1 and DLX4 were integrated with the exoge-
nous gene expression studies to identify all genes in the AAGS that could be
mapped as T of IKZF1 and DLX4. This was done by intersecting the ARACNe
regulons of IKZF1 and DLX4 with the AAGS. The intersection of these two sets
was then screened in the expression studies for any genes that respondedwith
at least 25% fold change. This set of genes was used to construct a consensus
‘‘meta-activity’’ for the IKZF1 and DLX4 loci. The rank-normalized change of
each gene across the AA patient cohort was integrated into an average as a
consensus measure of the relative activity of the parent MR.
These values were subsequently used to define a 2D search space, ðX3YÞ,
where X = IKZF1 meta-activity and Y = DLX4 meta-activity, to classify each of
the patients in the AA training set. The meta-activity vectors were rank trans-
formed such that the minimum values were bound to the origin of the search
space (0,0) and such that activity measures were positive. This transformation
has no influence on the results other than projecting the search space into a
more intuitive grid for display purposes, in which both axes are bound between
[0,n], where n is positive.
Classification in this spacewas done using amodified nonlinear, soft-margin
SVM algorithm. The algorithm is formalized:
X = ranksortðactivityIKZF1Þ
Y = ranksortðactivityDLX4Þ
defineðA3BÞ : ca˛X; arg max
b˛Y
fða;bÞ=

pðSj ;QIÞ3pðSi ;QIIIÞ
pðSi ;QIÞ3pðSj ;QIIIÞ
 :
The algorithm defines a vector set ðA3BÞ, which exists within the search space
ðX3YÞ, such that every given pair ða;bÞ maximizes the likelihood ratio fða;bÞ.
This function is defined such that Sj is the next order of disease severity to Si
andQI andQIII are the quadrants I and III of the grid created by the hyperplanes
ða3RÞ and ðR3bÞ. Samples in the training set are mapped to each grid with
known molecular subtypes and the likelihood ratio is computed for the segre-
gation of subtypes defined by S. The severity ranking used for Swas Normal <
Mild < Severe. Each coordinate set in ðA3BÞ therefore defines the points to a
nonlinear plane that maximizes the separation between samples of different
molecular classes in the IKZF1/DLX4 meta-activity space.
Cytotoxicity Assay
PBMC-dependent cytotoxicity wasmeasured using the CytoTox 96 Nonradio-
active Cytotoxicity Assay available through Promega. For the processing of
samples and solutions, we followed manufacturer protocols. The optimization
for PBMC:T was done as below, but using variable concentrations (1:1, 5:1,
and 10:1) (Figure S3).
Cytotoxicity experiments were set up in 96-well format, with each treatment
done in triplicate. Transfections were done 36 hr prior to the experiment. The
day of the experiment,HK andhuDPcells were trypsinized anddilutedwithDul-
becco’s modified Eagle’s medium (DMEM) into working stocks. The T concen-
trationperwellwas80,000cells in 50ml DMEM,combinedwith800,000PBMCs.336 Cell Systems 1, 326–337, November 25, 2015 ª2015 Elsevier IncThe NKG2D inhibitor was the Human NKG2D MAb (clone 149810) from R&D
Systems (Cat. MAB139), used at a final concentration of 20 mg/ml. Each trans-
fection was allocated in triplicate according to manufacturer instructions.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cels.2015.11.001.
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